[1]
|
K. H. Jacobsen and J. S. Koopman, “Declining Hepatitis A Seroprevalence: A Global Review and Analysis,” Epidemiology and Infection, Vol. 132, No. 6, 2004, pp. 1005-1022. doi:10.1017/S0950268804002857
|
[2]
|
S. Krugman, J. P. Giles and J. Hammond, “Infectious Hepatitis. Evidence for Two Distinctive Clinical, Epidemiological and Immunological Types of Infection,” Journal of the American Medical Association, Vol. 200, No.5, 1967, pp. 365-373. doi:10.1001/jama.200.5.365
|
[3]
|
S. J. Staes, T. L. Schlenker, I. Risk, K.G. Cannon, H. Haris and A. T. Pavia, “Sources of Infection among Persons with Acute Hepatitis A and No Identified Risk Factors during a Sustained Community-Wide Outbreaks,” Pediatrics, Vol. 106, No. 4, 2000, pp. E54.
doi:10.1542/peds.106.4.e54
|
[4]
|
P. Mathur and N. K. Arora, “Epidemiological Transition of Hepatitis A in India: Issues for Vaccination in Developing Countries,” Indian Journal of Medical Research, Vol. 128, No. 6, 2008, pp. 699-704.
|
[5]
|
G. De Serres, T. I. Cromeans, B. Levesque, M. Brassard, C. Barthe, M. Dionne, H. Prudhomme, D. Paradis, C. N. Shapiro, O. V. Nainan and H. S. Margolis, “Molecular Confirmation of Hepatitis A Virus from Well Water, Epidemiology and Public Health Implications,” Journal of Infectious Diseases, Vol. 179, No. 1, 1999, pp. 37-43.
doi:10.1086/314565
|
[6]
|
S. M. Feinstone, A. Z. Kapikan and R. H. Purcell, “Hepatitis A: Detection by Immune Electron Microscopy of a Virus-Like Antigen Associated with Acute Illness,” Science, Vol. 182, No. 116, 1973, pp. 1026-1028.
doi:10.1126/science.182.4116.1026
|
[7]
|
B. B. Goswami, W. Burkhardt and T. A. Cebula, “Identification of Genetic Variants of Hepatitis A Virus,” Journal of Virological Methods, Vol. 65, No. 1, 1997, pp. 95- 103. doi:10.1016/S0166-0934(97)02179-4
|
[8]
|
T. I. Cromeans, O. V. Nainan and H. S. Margolis, “Detection of Hepatitis A Virus RNA in Oyster Meat,” Applied and Environmental Microbiology, Vol. 63, No. 6, 1997, pp. 2460-2463.
|
[9]
|
J. Jean, B. Blais, A. Darvean and I. Fliss, “Detection of Hepatitis A Virus by Nucleic Acid Sequence-Based Amplification Technique and Comparison with Reverse Transcription-PCR,” Applied and Environmental Microbiology, Vol. 67, No. 12, 2001, pp. 5593-5600.
doi:10.1128/AEM.67.12.5593-5600.2001
|
[10]
|
B. P. Bell, “Global epidemiology of hepatitis A: implications for control strategies,” In: H. S. Margolis, M. J. Alter, J. T. Liand and J. I. Dienstag, Eds., Viral Hepatitis and Liver Disease, International Medical Press, London, 2005, pp. 9-14,.
|
[11]
|
S. R. Bialek, D. A. Thoroughman, D. Hu, E. P. Simard, J. Chattin, J. Cheek and B. P. Bell, “Hepatitis A Incidence and Hepatitis A Vaccination among American Indians and Alaska Natives 1990-2001,” American Journal of Public Health, Vol. 94, No. 6, 2004, pp. 996-1001.
doi:10.2105/AJPH.94.6.996
|
[12]
|
A. E. Fiore , A. Wasley and B. P. Bell, “Prevention of Hepatitis A through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practice (ACIP),” MMWR Recommendations and Reports, Vol. 55, No. RR-7, 2006, pp. 1-23.
|
[13]
|
N. S. Crowcroft, B. Walsh and K. L. Davison, “Gundabissoon U on Behalf of PHLS Advisory Committee on Vaccination and Immunization, Guidelines for the Control of Hepatitis A Virus Infection,” Communicable Disease and Public Health, Vol. 4, No. 3, 2001, pp. 213-227.
|
[14]
|
C. T. Leach, “Hepatitis A in the United States,” Pediatric Infectious Disease Journal, Vol. 23, No. 6, 2004, pp. 551- 553. doi:10.1097/01.inf.0000130071.03003.c2
|
[15]
|
B. Pham, B. Duval, G. De Serres, V. Gilca, A. C. Tricco, J. Ochnio and D. W. Scheifele, “Seroprevalence of Hep- atitis A, Infection in a Low Endemicity Country: A Sys- tematic Review,” BMC Infectious Diseases, Vol. 5, 2005, p. 56. doi:10.1186/1471-2334-5-56
|
[16]
|
K. Van Herck, P. Van Damme, F. Castelli, J. Zuckerman, H. Nothdurft, A. L. Dahlgren, S. Gisler, R. Steffen, P. Gargalianos, R. Lopéz-Vélez, D. Overbosch, E. Caumes, E. Walker, “Knowledge, Attitudes and Practices in Travel- Related Infectious Diseases: The European Airport Survey,” Journal of Travel Medicine, Vol. 11, No. 1, 2004, pp. 3-8. doi:10.2310/7060.2004.13609
|
[17]
|
H. D. Nothdurft, A. La Dahlgren, E. A. Gallagher, H. Kollaritsch, D. Overbosch, M. L. Rummukainen, P. Rendi-Wagner, R. Steffen and P. Van Damme, “The Risk of Acquiring Hepatitis A and B among Travelers in Selected Eastern and Southern Europe and Non-European Mediterranean Countries: Review and Consensus Statement on Hepatitis A and B Vaccination,” Journal of Travel Medicine, Vol. 14, No. 3, 2007, pp. 181-187.
doi:10.1111/j.1708-8305.2007.00123.x
|
[18]
|
B. Genton, V. D’Acremont, H. J. Furrer, C. Hatz and L. Loutan, “Hepatitis A Vaccines and the Elderly,” Travel Medicine and Infectious Disease, Vol. 4, No. 6, 2006, pp. 303-312. doi:10.1016/j.tmaid.2005.10.002
|
[19]
|
N. Vatev, M. Atanasova, J. Stoilova, T. Chervenyakova and M. Troyancheva, “Seroprevalence of Hepatitis A Viral Infection in Plovdiv, Bulgaria,” Folia Medica, Vol. 1, 2009, pp. 70-73.
|
[20]
|
M. Kojouharova and Editorial Team, “Current Outbreak of Hepatitis A in Bulgaria, 2006,” European Surveillance, Vol. 11, No. 40, 2006, pp. 30-49.
|